Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 18, 2022

SELL
$34.2 - $51.69 $75,069 - $113,459
-2,195 Reduced 7.54%
26,924 $921,000
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $566,282 - $1.22 Million
24,472 Added 526.62%
29,119 $1.01 Million
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $344,403 - $798,688
-12,402 Reduced 72.74%
4,647 $204,000
Q4 2021

Feb 15, 2022

BUY
$54.9 - $105.21 $633,436 - $1.21 Million
11,538 Added 209.36%
17,049 $1.07 Million
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $50,085 - $85,082
477 Added 9.48%
5,511 $581,000
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $629,803 - $906,120
5,034 New
5,034 $891,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.57B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.